Suggested Searches

photo of Wangjian Zhong
502-897-1166

Wangjian Zhong, MD

Hematology Oncology
Gender: Male
4.9 of 5 (169 Ratings)
Accepting New Patients
Virtual Visits

Practice Locations

A:
Baptist Health Medical Group Hematology & Oncology
4003 Kresge Way, Suite 500
Louisville, KY 40207
502-897-1166 502-897-1461
B:
Baptist Health Louisville Multi-Disciplinary Clinic
4003 Kresge Way
Louisville, KY 40207
502-896-3009 502-259-4097
C:
Baptist Health Medical Group Hematology & Oncology
2400 Eastpoint Parkway, Suite 310
Louisville, KY 40223
502-897-1166 502-897-1461
D:
Baptist Health Medical Group Hematology & Oncology
1031 New Moody Lane, Suite 204
La Grange, KY 40031
502-897-1166 502-897-1461

Education

Medical School

Shanghai University of Traditional Chinese Med

Residency

Indiana University School of Medicine

Fellowship

University of Louisville

Board Certifications

Medical Oncology

American Board of Internal Medicine

Hematology

American Board of Internal Medicine

Hospital Affiliations

  • Baptist Health LaGrange
  • Baptist Health Louisville

Philosophy of Care

Baptist Health Medical Group is a comprehensive, multispecialty network of physicians and advanced practice clinicians. Our providers are committed to providing compassionate, patient-centered care and strive to treat our patients the way we would want to be treated, every time, at every Baptist Health location.

Reviews

Patient Experience Ratings

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Overall Rating
4.9 out of 5 (169 Ratings)
Review Categories
Patient Comments

Research

  • Cancer

    Ascend 2: Detecting cancers Earlier Through Elective plasma-based CancerSEEK Testing – Ascertaining Serial Cancer patients to Enable New Diagnostic II (DETECT-ASCEND 2)

    Trial Details
  • Chronic Lymphocytic Leukemia (WIRB-22-0123)

    LOXO Lilly: A Phase 3 Open-Label, Randomized Study of Pirtobrutinib (LOXO-305) versus Ibrutinib in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN-CLL-314)

    Trial Details
  • Non Small Cell Lung Cancer

    QUILT -2.023:A phase 2, open-label, randomized study of ALT-803 in combination with pembrolizumab vs pembrolizumab alone as first-line treatment for patients with metastatic NSCLC

    Trial Details
  • NSC Lung Cancer

    Razor-Encore - A Randomized Prospective Trial of Adjuvant Chemotherapy in Patients With Completely Resected Stage I or IIA Non-Squamous Non-Small Cell Lung Cancer Identified as Intermediate or High Risk by a 14-Gene Prognostic Assay

    Trial Details